Table
6:
Primary and secondary outcomes based on HBP* and CBP** at endpoint in 96
overweight patients with type 2 diabetes mellitus.
Outcomes 
Patient
status: HBP* endpoint in
96 overweight patients 
Patient status:
CBP** at endpoint in 96 overweight patients 


Hypertension (n = 30) 
Normotension (n = 66) 
Hazard ratio (95% CI) 
P 
Hypertension (n = 42) 
Normotension (n = 54) 
Hazard ratio (95% CI) 
P 
Primary outcome 


Death 
13 
8 
3.6 (1.710.5) 
0.0244 
12 
9 
1.6 (0.73.7) 
0.2976 
Secondary outcome 


Microvascular
complications 
21 
34 
2.1 (1.86.6) 
0.0010 
16 
31 
1.0 (0.51.8) 
0.9496 
Macrovascular
complications 
9 
6 
3.2 (1.311.0) 
0.0184 
7 
8 
1.1 (0.63.0) 
0.8795 
The overweight
was defined by as the criteria of Japan Society for the Study of Obesity. Body
mass Index (BMI) with from < 25.0 kg/m^{2} to < 30 kg/m^{2 }was
defined as overweight. The 400 patients in each group were classified as having
overweight and hypertension or normotension according to values of blood pressure as same
threshold with less than 130 mmHg of systolic blood pressure measured in the
home (HBP*) and in the clinic (CBP**) at endpoint, respectively. Differences
in primary and secondary outcomes for events between overweight patients with
hypertension and normotension measured at endpoint
in each group were assessed using survival curves from the KaplanMeier method,
and comparisons were analyzed using hazard ratio by
the logrank test. CI, confidence interval. Twotailed values of P < 0.05
were defined as statistically significant